This website sets cookies which are used to offer a personalized experience on our website, generate statistics, and realize advertising or social network tracking. Find out more about our Privacy & Cookie policy and how to manage them on your browser. You can change your cookie settings at any time.

HEV Pathogenesis & Treatment | Rom 715

Thursday, June 14, 2018
4:15 PM to 6:00 PM

Chairs: Heiner Wedemeyer & Jacques Izopet

Invited Presentations:

HEV and emerging worldwide pathogen? Shiv Sarin, Institute Of Liver And Biliary Sciences, New Delhi

Treatment of HEV infection Heiner Wedemeyer, University Hospital Essen, Essen

HEV in immunocompromised patients Ken Sherman, University Of Cincinnati College Of Medicine, Cincinnati

Oral Abstracts:

Hepatitis E - Profile And Predictors Of Mortality: Indian Experience Aradya Venu, St. John’s Medical College Hospital, Bengaluru

Association between liver fibrosis and HEV seroprevalence among HIV-positive individuals in Nepal Jose Debes, University Of Minnesota, Minneapolis